Cyclerion Therapeutics (CYCN) SEC Filings & 10K Form $2.42 -0.31 (-11.36%) Closing price 04:00 PM EasternExtended Trading$2.38 -0.04 (-1.45%) As of 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share SEC Filings Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Recent Cyclerion Therapeutics SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel DateFilerForm TypeView09/23/20253:14 PMCyclerion Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 06/18/20253:41 PMCyclerion Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/15/202511:15 PMCyclerion Therapeutics (Filer)Form EFFECT05/07/20254:25 PMCyclerion Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/07/20254:21 PMCyclerion Therapeutics (Filer)Form 424B505/06/20253:56 PMCyclerion Therapeutics (Filer)Form S-3Registration statement under Securities Act of 1933 03/28/20258:47 PMCyclerion Therapeutics (Subject)Hecht Peter M (Filed by)Form SCHEDULE 13D/A03/27/20257:38 PMCyclerion Therapeutics (Issuer)Hecht Peter M (Reporting)Form 4Statement of changes in beneficial ownership of securities 03/25/20253:40 PMCyclerion Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 02/12/202511:15 PMCyclerion Therapeutics (Filer)Form EFFECT02/12/20252:36 PMCyclerion Therapeutics (Subject)MFN Partners Management, LP (Filed by)Form SCHEDULE 13G/A02/12/202512:25 PMAmerican Endowment Foundation (Filed by)Cyclerion Therapeutics (Subject)Form SCHEDULE 13G/A02/12/20258:28 AMCyclerion Therapeutics (Subject)FMR LLC (Filed by)Form SCHEDULE 13G/A02/04/20253:40 PMCyclerion Therapeutics (Filer)Form S-3Registration statement under Securities Act of 1933 12/17/20247:16 AMCyclerion Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/25/20243:05 PMCyclerion Therapeutics (Issuer)Greenspan David Gerald (Reporting)Slate Path Capital LP (Reporting)Form 4Statement of changes in beneficial ownership of securities (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies Adaptimmune Therapeutics SEC Filings BioXcel Therapeutics SEC Filings X4 Pharmaceuticals SEC Filings Alterity Therapeutics SEC Filings Tempest Therapeutics SEC Filings Xilio Therapeutics SEC Filings Jasper Therapeutics SEC Filings Generation Bio SEC Filings Dyadic International SEC Filings Pluri SEC Filings SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:CYCN) was last updated on 9/26/2025 by MarketBeat.com Staff From Our PartnersWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclerion Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclerion Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYCN Stock Alerts